This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
2 I Goldsmith , AGG Turpie , GYH Lip . ABC of antithrombotic therapy. Valvuar heart disease and prosthetic heart valves. Br Med J 2002; 325: 1228–231.
3 DN Salem , PD Stein , A Al-Ahmad , HI Bussey , D Horskotte , N Miller Antithrombotic therapy in valvular heart disease – native and prosthetic: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 457–82.
4 EM Baudet , V Puel , JT McBride , JP Grimaud , F Roques , F Clerc Long-term results of valve replacement with the St. Jude Medical prosthesis. J Thorac Cardiovasc Surg 1995; 109: 858–70.
5 VO Bjork , A Henze . Management of thrombo-embolism after aortic valve replacement with the Bjork-Shiley tilting disc valve: medicamental prevention with dicumarol in comparison with dipyrimidamole-acetylsalicylic acid; surgical treatment of prosthetic thrombosis. Scand J Thorac Cardiovasc Surg 1975; 9: 183–91.
6 JC Cappelleri , LD Fiore , MT Brophy , D Deykin , J Lau . Efficacy and safety of combined anticoagulant and antiplatelet therapy versus anticoagulant monotherapy after mechanical heart valve replacement: a meta analysis. Am Heart J 1995; 130: 547–52.
7 D Born , EE Martinez , PAM Almeida , DV Santos , ACC Carvalho , AF Moron . Pregnancy in patients with prosthetic heart valves: the effect of anticoagulation on mother, fetus and neonate. Am Heart J 1992; 124: 413–17.
8 E Sbarouni , CM Oakley . Outcome of pregnancy in women with valve prostheses. Br Heart J 1994; 71: 196–201.
11 CE Denbow , L Matadial , S Sivapragasam , H Spencer . Pregnancy in patients after homograft cardiac valve replacement. Chest 1983; 83: 540–42.
12 A Dore , J Somerville . Pregnancy in patients with pulmonary autograft valve replacement. Eur Heart J 1997; 18: 1659–62.
16 RB Gherman , TM Goodwin , B Leung , JD Byrne , R Hethumumi , M Montoro . Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy. Obstet Gynecol 1999; 94: 730–34.
17 JG Ray , WS Chan . Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and the leg of presentation. Obstet Gynecol Surv 1999; 54: 265–71.
19 JAG Hall , RM Paul , KM Wilson . Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 1980; 68: 122–140.
20 WS Chan , S Anand , JS Ginsberg . Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Int Med 2000; 160: 191–96.
21 F Robin , F Lecuru , P Desfeux , B Boucaya , R Taurelle . Anticoagualation therapy in pregnancy. Eur J Obstet Gynecol Reprod Biol 1999; 83: 171–77.
23 JS Ginsberg , G Kowalchuk , J Hirsh , P Brill-Edwards , R Burrows . Heparin therapy during pregnancy: risk to the fetus and mother. Arch Int Med 1989; 149: 2233–36.
24 Y Shapira , A Sagie , A Battler . Low-molecular-weight heparin for the treatment of patients with mechanical heart valves. Clin Cardiol 2002; 25: 323–27.
25 JB Groce . “Bridging” therapy with low molecular weight heparin in pregnant patients and patients with mechanical prosthetic heart valves. J Thromb Thrombolysis 2003; 16: 79–82.
26 PD Stein , JS Alpert , HI Bussey , JE Dalen , AGG Turpie . Antithrombotic therapy in patients with mechanical and bioprosthetic heart valves. Chest 2001; 119: 220–27.
29 SM Bates , IA Greer , J Hirsh , JS Ginsberg . Conference on antithrombotic and thrombolytic therapy use of antithrombotic agents during pregnancy – The seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 627–44.
30 J Lepercq , J Conard , A Borel-Derlon , JY Darmon , O Boudignat , C Francoual Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies. BJOG 2001; 108: 1134–140.
31 F Forestier , F Daffos , M Capella-Pavlovsky . Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy: study by direct fetal blood sampling under ultrasound. Thromb Res 1984; 34: 557–60.
34 C Nelson-Piercy , EA Letsky , M de Swiet . Low molecular weight heparin for obstetric thromboprophylaxis: experience of sixty-nine pregnancies in sixty-one women at high risk. Am J Obstet Gynecol 1997; 176: 1062–1068.
35 TE Warkentin , MN Levine , J Hirsh , P Horsewood , RS Roberts , M Gent Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. NEJM 1995; 332:1330–336.
36 HW de Valk , JD Banga , JW Wester , CB Brouwer , MW van Hessen , OJ Meuwissen Comparing subcutaneous danaparoid with intravenous unfractionated heparin for the treatment of venous thromboembolism: a randomized controlled trial. Ann Intern Med 1995; 123: 1–9.
39 TC Dahlman . Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin. Am J Obstet Gynecol 1993; 168: 1265–270.
43 ID Bradbrook , HN Magnani , HC Moelker , PJ Morrison , J Robinson , HJ Rogers ORG 10172: a low molecular weight heparinoid anticoagulant with a long half life in man. Br J Clin Pharmacol 1987; 23: 667–75.
46 E Holmer , K Kurachi , G Soderstrom . The molecular-weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin, factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombin. Biochem J 1981; 193: 395–400.
48 L Bara , E Billaud , G Gramond , A Kher , M Samama . Comparative pharmacokinetics of low molecular weight heparin and unfractionated heparin after intravenous and subcutaneous administration. Thromb Res 1985; 39: 631–36.
55 JS Ginsberg , WS Chan , SM Bates , S Kaatz . Anticoagulation of pregnant women with mechanical heart valves. Arch Intern Med 2003; 163: 694–98.
56 TF Imperiale , AS Petrulis . A meta-analysis of low-dose aspirin for prevention of pregnancy-induced hypertensive disease. JAMA 1991; 266: 260–64.
57 U Elkayam , H Singh , A Irani , MW Akhter . Anticoagulation in Pregnant Women With Prosthetic Heart Valves. J Cardiovasc Pharmacol Ther 2004; 9: 107–15.
58 JA Rowan , LM McCowan , PJ Raudkivi , RA North . Enoxaparin treatment in women with mechanical heart valves during pregnancy. Am J Obstet Gynecol 2001; 185: 633–37.
61 R Bauersachs , E Lindhoff-Last . Anticoagulation of pregnant women with mechanical heart valves using low-molecular-weight heparin. Arch Intern Med 2003; 163: 2788–789.
62 P Behrendt , B Schwartzkopff , S Perings , A Gerhardt , RB Zotz , AB Stauer . Successful thrombolysis of St. Jude Medical Aortic Prosthesis with tissue-type plasminogen activator in a pregnant woman: A case report. Cardiol Rev 2002; 10: 349–53.
63 J Ellison , AJ Thomson , ID Walker , IA Greer . Use of enoxaparin in a pregnant woman with a mechanical heart valve prosthesis. BJOG 2001; 108: 757–59.
66 O Lev-Ran , A Kramer , J Gurevitch , I Shapira , R Mohr . Low-molecular weight heparin for prosthetic heart valves: treatment failure. Ann Thoracic Surg 2000; 69: 264–66.
67 RG Leyh , S Fischer , A Ruhparwar , A Haverich . Anticoagulation for prosthetic heart valves during pregnancy: Is low-molecular-weight heparin an alternative? Eur J Cardiothorac Surg 2002; 21; 577–79.
71 D Oles , R Berryessa , K Campbell , MA Bhatti . Emergency redo mitral valve replacement in a 27-year-old pregnant female with a clotted prosthetic mitral valve, preoperative fetal demise and postoperative ventricular assist device: a case report. Perfusion 2001; 16: 159–64.
72 N Roberts , D Ross , S Flint , R Arya , M Blott . Thromboembolism in pregnant women with mechanical prosthetic heart valves anticoagulated with low molecular-weight heparin. BJOG 2001; 108: 327–29.
73 MA Geelani , S Singh , A Verma , A Nagesh , V Betigeri , M Nigam . Anticoagulation in patients with mechanical valves during pregnancy. Asian Cardiovasc Thorac Ann 2005; 13: 30–33.
76 WA Evans , SA Laifer , TJ McNanley , A Ruzycky . Management of Thromboembolic Disease Associated With Pregnancy. J Matern Fetal Med 1997; 6: 21–27.